BridgeMD
New treatment option for Spinal Cord Injury
Official title Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury
ClinicalTrials.gov ID: NCT07501429
What this study is testing
- What it's testing
- Approximately 305,000 people live with a spinal cord injury (SCI) in the United States. Sixty percent of these individuals have tetraplegia, which can cause significant dysfunction of the arms and hands.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older.
- Have chronic, non-progressive SCI of all levels and severities that occurred greater than 1 year prior to their enrollment.
- MAS score of between 1+ and 3 in elbow and wrist flexors of the treated upper limb.
- Can be treated with shockwaves. Contraindications include current or recent (within the past 3 months) infection at the site of treatment and severe...
- No change in antispasmodic medications within the past three months or intended changes over the course of the trial.
You likely can't join if
- History of surgical procedures in the upper extremity
- Severe, inflammatory arthritic diseases
- Thrombosis
- Anticoagulant medication;
- Pregnancy
- Cancer
See the full eligibility criteria
- 18 years of age or older.
- Have chronic, non-progressive SCI of all levels and severities that occurred greater than 1 year prior to their enrollment.
- MAS score of between 1+ and 3 in elbow and wrist flexors of the treated upper limb.
- Can be treated with shockwaves. Contraindications include current or recent (within the past 3 months) infection at the site of treatment and severe coagulopathies (e.g. hemophilia).129
- No change in antispasmodic medications within the past three months or intended changes over the course of the trial.
- Participant is able and willing to comply with the protocol.
- History of surgical procedures in the upper extremity
- Severe, inflammatory arthritic diseases
- Thrombosis
- Anticoagulant medication;
- Pregnancy
- Cancer
- Recent history of local injection of botulinum toxin within 6 months, or phenol/alcohol within the 12 months
The study team makes the final eligibility decision.
Where it's taking place
- West Orange, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include West Orange, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.